Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study

• Päätekijät: Ernesto Rossi (Tekijä), Luca Boldrini (Tekijä), Maria Grazia Maratta (Tekijä), Roberto Gatta (Tekijä), Claudio Votta (Tekijä), Giampaolo Tortora (Tekijä), Giovanni Schinzari (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Taylor & Francis Group, 2023-01-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Immunotherapy has become a cornerstone for the treatment of renal cell carcinoma. Nevertheless, some patients are resistant to immune checkpoint inhibitors. The possibility to identify patients who cannot benefit from immunotherapy is a relevant clinical challenge. We analyzed the association betwee...